GT201300252A - Alfa glucosidasa ácida modificada con procesamiento acelerado - Google Patents
Alfa glucosidasa ácida modificada con procesamiento aceleradoInfo
- Publication number
- GT201300252A GT201300252A GT201300252A GT201300252A GT201300252A GT 201300252 A GT201300252 A GT 201300252A GT 201300252 A GT201300252 A GT 201300252A GT 201300252 A GT201300252 A GT 201300252A GT 201300252 A GT201300252 A GT 201300252A
- Authority
- GT
- Guatemala
- Prior art keywords
- accelerated processing
- modified acid
- alfa
- glucosidase modified
- glucosidase
- Prior art date
Links
- 102000004366 Glucosidases Human genes 0.000 title 1
- 108010056771 Glucosidases Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 101001018026 Homo sapiens Lysosomal alpha-glucosidase Proteins 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 102000045921 human GAA Human genes 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161478336P | 2011-04-22 | 2011-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT201300252A true GT201300252A (es) | 2015-02-09 |
Family
ID=46000406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT201300252A GT201300252A (es) | 2011-04-22 | 2013-10-18 | Alfa glucosidasa ácida modificada con procesamiento acelerado |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20140186326A1 (enExample) |
| EP (1) | EP2699676A1 (enExample) |
| JP (2) | JP2014513952A (enExample) |
| KR (1) | KR20140037082A (enExample) |
| CN (1) | CN103797115A (enExample) |
| AU (1) | AU2012245280A1 (enExample) |
| BR (1) | BR112013026976A2 (enExample) |
| CA (1) | CA2833371A1 (enExample) |
| CL (1) | CL2013003010A1 (enExample) |
| CO (1) | CO6811810A2 (enExample) |
| CR (1) | CR20130555A (enExample) |
| EC (1) | ECSP13013036A (enExample) |
| GT (1) | GT201300252A (enExample) |
| IL (1) | IL228871A0 (enExample) |
| MA (1) | MA35125B1 (enExample) |
| MX (1) | MX2013012345A (enExample) |
| NI (1) | NI201300110A (enExample) |
| PE (1) | PE20140617A1 (enExample) |
| PH (1) | PH12013502149A1 (enExample) |
| RU (1) | RU2013151875A (enExample) |
| SG (2) | SG194486A1 (enExample) |
| TN (1) | TN2013000427A1 (enExample) |
| WO (1) | WO2012145644A1 (enExample) |
| ZA (1) | ZA201307696B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014130723A1 (en) | 2013-02-20 | 2014-08-28 | Valerion Therapeutics, Llc | Methods and compositions for treatment of pompe disease |
| HUE064629T2 (hu) | 2014-09-30 | 2024-04-28 | Amicus Therapeutics Inc | Nagy potenciálú savas alfa-glükozidáz fokozott szénhidrátokkal |
| WO2017079729A1 (en) * | 2015-11-06 | 2017-05-11 | Biomarin Pharmaceutical Inc. | Cell-based assays for detection of antibodies or other factors that neutralize uptake of lysosomal enzymes |
| SG11201804965SA (en) | 2015-12-30 | 2018-07-30 | Amicus Therapeutics Inc | Augmented acid alpha-glucosidase for the treatment of pompe disease |
| KR102343162B1 (ko) | 2016-03-30 | 2021-12-23 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 고 m6p 재조합 단백질의 선택 방법 |
| KR20250017756A (ko) | 2016-03-30 | 2025-02-04 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 재조합 산 알파-글루코시다제를 포함하는 제형 |
| EP3293260A1 (en) | 2016-09-12 | 2018-03-14 | Genethon | Acid-alpha glucosidase variants and uses thereof |
| EP3293203A1 (en) | 2016-09-12 | 2018-03-14 | Genethon | Acid-alpha glucosidase variants and uses thereof |
| AU2017322376B2 (en) | 2016-09-12 | 2023-08-17 | Association Institut De Myologie | Acid-alpha glucosidase variants and uses thereof |
| EP3293259A1 (en) | 2016-09-12 | 2018-03-14 | Genethon | Acid-alpha glucosidase variants and uses thereof |
| SI3624831T1 (sl) | 2017-05-15 | 2023-08-31 | Amicus Therapeutics, Inc. | Rekombinantna humana kisla alfa-glukozidaza |
| IL271193B2 (en) | 2017-06-07 | 2025-01-01 | Regeneron Pharma | Preparations and methods for internalizing enzymes |
| KR101942093B1 (ko) * | 2018-01-05 | 2019-01-24 | 인하대학교 산학협력단 | 만노시다제 억제제를 포함하는 고만노즈 타입 n-당쇄를 갖는 인간 리소좀 효소 생산용 조성물 |
| EP3749373A1 (en) | 2018-02-07 | 2020-12-16 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for therapeutic protein delivery |
| JP7477462B2 (ja) | 2018-05-17 | 2024-05-01 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 抗ｃｄ６３抗体、コンジュゲート、及び、それらの使用 |
| US20220331408A1 (en) | 2019-07-09 | 2022-10-20 | Genethon | Treatment of glycogen storage disease (gsd) |
| IL293068A (en) * | 2019-11-19 | 2022-07-01 | Asklepios Biopharmaceutical Inc | Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071890A (en) | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| US5952516A (en) | 1997-05-08 | 1999-09-14 | Genzyme Corporation | Cationic amphiphiles containing multiplesteroid lipophilic groups |
| CA2305768A1 (en) | 1997-10-29 | 2000-02-24 | Genzyme Corporation | Compositions and methods for treating lysosomal storage disease |
| US6287857B1 (en) | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
| GB9807464D0 (en) * | 1998-04-07 | 1998-06-10 | Pharming Bv | Purification of human acid µ-glucosidase |
| JP4990434B2 (ja) * | 1998-12-07 | 2012-08-01 | ジェンザイム・コーポレーション | ポンペ病の処置 |
| US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| US7001994B2 (en) | 2001-01-18 | 2006-02-21 | Genzyme Corporation | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins |
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| JP4742191B2 (ja) * | 2001-06-14 | 2011-08-10 | 独立行政法人産業技術総合研究所 | 糖蛋白質およびその製造方法 |
| ES2395463T3 (es) | 2001-07-16 | 2013-02-15 | Genzyme Corporation | Un inhibidor de N-acilesfingosina glucosiltransferasa |
| AU2002348261A1 (en) | 2001-11-26 | 2003-06-10 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| US6916802B2 (en) | 2002-04-29 | 2005-07-12 | Genzyme Corporation | Amino ceramide-like compounds and therapeutic methods of use |
| US20040248262A1 (en) * | 2003-01-22 | 2004-12-09 | Koeberl Dwight D. | Constructs for expressing lysomal polypeptides |
| US20100196345A1 (en) | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
| CN1813066B (zh) | 2003-06-24 | 2010-04-28 | 建新公司 | 新的β-肌动蛋白和RPS21启动子及其应用 |
| CA2553955C (en) | 2004-02-10 | 2012-08-28 | Zystor Therapeutics, Inc. | Acid alpha-glucosidase and fragments thereof |
| WO2008063511A2 (en) * | 2006-11-13 | 2008-05-29 | Zystor Therapeutics, Inc. | Methods for treating pompe disease |
| HUE044381T2 (hu) | 2008-12-16 | 2019-10-28 | Genzyme Corp | Szintetikus intermedierek oligoszacharid-fehérje konjugátumok elõállításához |
| WO2010096369A1 (en) * | 2009-02-18 | 2010-08-26 | Amicus Therapeutics, Inc. | Mouse model for pompe disease and methods of use thereof |
-
2012
- 2012-04-20 JP JP2014506579A patent/JP2014513952A/ja active Pending
- 2012-04-20 CN CN201280030662.2A patent/CN103797115A/zh active Pending
- 2012-04-20 PH PH1/2013/502149A patent/PH12013502149A1/en unknown
- 2012-04-20 PE PE2013002377A patent/PE20140617A1/es not_active Application Discontinuation
- 2012-04-20 SG SG2013076526A patent/SG194486A1/en unknown
- 2012-04-20 CA CA2833371A patent/CA2833371A1/en not_active Abandoned
- 2012-04-20 US US14/113,360 patent/US20140186326A1/en not_active Abandoned
- 2012-04-20 SG SG10201605874TA patent/SG10201605874TA/en unknown
- 2012-04-20 BR BR112013026976A patent/BR112013026976A2/pt not_active IP Right Cessation
- 2012-04-20 KR KR1020137029936A patent/KR20140037082A/ko not_active Withdrawn
- 2012-04-20 MX MX2013012345A patent/MX2013012345A/es not_active Application Discontinuation
- 2012-04-20 RU RU2013151875/10A patent/RU2013151875A/ru not_active Application Discontinuation
- 2012-04-20 WO PCT/US2012/034479 patent/WO2012145644A1/en not_active Ceased
- 2012-04-20 EP EP12717025.6A patent/EP2699676A1/en not_active Withdrawn
- 2012-04-20 AU AU2012245280A patent/AU2012245280A1/en not_active Abandoned
-
2013
- 2013-10-14 IL IL228871A patent/IL228871A0/en unknown
- 2013-10-16 ZA ZA2013/07696A patent/ZA201307696B/en unknown
- 2013-10-16 NI NI201300110A patent/NI201300110A/es unknown
- 2013-10-17 CL CL2013003010A patent/CL2013003010A1/es unknown
- 2013-10-18 TN TNP2013000427A patent/TN2013000427A1/fr unknown
- 2013-10-18 GT GT201300252A patent/GT201300252A/es unknown
- 2013-10-29 CR CR20130555A patent/CR20130555A/es unknown
- 2013-11-14 MA MA36431A patent/MA35125B1/fr unknown
- 2013-11-20 CO CO13272849A patent/CO6811810A2/es not_active Application Discontinuation
- 2013-11-21 EC ECSP13013036 patent/ECSP13013036A/es unknown
-
2016
- 2016-09-23 JP JP2016185075A patent/JP2017035091A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PE20140617A1 (es) | 2014-05-28 |
| NI201300110A (es) | 2014-02-28 |
| SG194486A1 (en) | 2013-12-30 |
| WO2012145644A1 (en) | 2012-10-26 |
| PH12013502149A1 (en) | 2019-09-02 |
| CN103797115A (zh) | 2014-05-14 |
| JP2017035091A (ja) | 2017-02-16 |
| KR20140037082A (ko) | 2014-03-26 |
| ECSP13013036A (es) | 2015-04-30 |
| CL2013003010A1 (es) | 2014-03-07 |
| EP2699676A1 (en) | 2014-02-26 |
| JP2014513952A (ja) | 2014-06-19 |
| AU2012245280A1 (en) | 2013-11-07 |
| ZA201307696B (en) | 2014-07-30 |
| TN2013000427A1 (en) | 2015-03-30 |
| CO6811810A2 (es) | 2013-12-16 |
| CA2833371A1 (en) | 2012-10-26 |
| MA35125B1 (fr) | 2014-05-02 |
| CR20130555A (es) | 2013-12-09 |
| SG10201605874TA (en) | 2016-09-29 |
| US20140186326A1 (en) | 2014-07-03 |
| MX2013012345A (es) | 2015-05-07 |
| RU2013151875A (ru) | 2015-05-27 |
| IL228871A0 (en) | 2013-12-31 |
| BR112013026976A2 (pt) | 2019-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201300252A (es) | Alfa glucosidasa ácida modificada con procesamiento acelerado | |
| MX2019009437A (es) | Tratamiento de mielosupresion. | |
| MX2015013590A (es) | Sistemas y metodos para la produccion dirigids de una proteina terapeutica dentro de una celula objetivo. | |
| BR112016016539A2 (pt) | micro-organismos recombinantes enriquecidos com carboidratos | |
| AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
| BR112017023516A2 (pt) | composição de polímero reforçado com fibra, e, artigo. | |
| BR112015009042A2 (pt) | populações de célula renal e usos das mesmas | |
| EA201690718A1 (ru) | Способ обработки целлюлозосодержащей биомассы | |
| UY33956A (es) | Anticuerpo del factor antitisular humano y sus usos para tratar cáncer | |
| MX2015016406A (es) | Formulacion de revestimiento para madera. | |
| MX377149B (es) | Microorganismo recombinante para la produccion mejorada de productos quimicos finos. | |
| MX378313B (es) | Produccion microbiana de dioles grasos. | |
| CL2018000671A1 (es) | Expresión de proteínas recombinantes en pupas de trichoplusia ni | |
| BR112017025322A8 (pt) | Processos integrados para recuperação de hidrolisato celulósico após hidrólise de polpa de celulose | |
| BR112015030655A2 (pt) | Variantes de xilanase e polinucleótidos que codificam as mesmas | |
| UY35438A (es) | Procedimiento para preparar inhibidores de la glucosilceramida sintasa. | |
| MX2017011976A (es) | Microorganismo recombinante para la produccion mejorada de quimicos finos. | |
| EA201891226A1 (ru) | Способ сокращения общего потребления электроэнергии при производстве наноцеллюлозы | |
| BR112015022266A2 (pt) | processo e sistema eletroquímicos para a produção de glicose | |
| BR112018010631A2 (pt) | uso de oxigênio dissolvido para inibir a produção de ácido láctico durante a propagação de levedura e/ou hidrólise de biomassa de lignocelulose | |
| BR112016029572A2 (pt) | variantes de exoglucanases que possuem atividade melhorada e utilizações das mesmas | |
| BR102012023867A2 (pt) | Método de pré-tratamento para produzir açúcares solúveis em água a partir de material lignocelulósico | |
| MX382334B (es) | Métodos para producir glucoproteínas recombinantes con glucosilación modificada. | |
| MX2017000785A (es) | Proceso de acetilacion de la madera. | |
| BR112012008017A2 (pt) | 1,2,4-triazina, utilização de uma 1,2,4-triazina e processo de preparação de uma 1,2,4-triazina |